VP-16 AND CISPLATIN IN THE TREATMENT OF NON-SMALL-CELL LUNG-CANCER

被引：0
|
作者：
KLASTERSKY, J
机构：
来源：
SEMINARS IN ONCOLOGY | 1985年 / 12卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：17 / 20
页数：4
相关论文
共 50 条
  • [1] TREATMENT OF NON-SMALL CELL LUNG-CANCER WITH CISPLATIN, VP-16, AND MYTOMICIN
    ARRAZTOA, J
    ORLANDI, L
    RODRIGUEZ, R
    VOGEL, C
    RAMIREZ, G
    REVISTA MEDICA DE CHILE, 1987, 115 (01) : 31 - 36
  • [2] ETOPOSIDE (VP-16) AND CISPLATIN - AN EFFECTIVE TREATMENT FOR RELAPSE IN SMALL-CELL LUNG-CANCER
    EVANS, WK
    OSOBA, D
    FELD, R
    SHEPHERD, FA
    BAZOS, MJ
    DEBOER, G
    JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (01) : 65 - 71
  • [3] TREATMENT OF SMALL-CELL LUNG-CANCER WITH VP-16 AND IFOSFAMIDE
    WESTERHAUSEN, M
    WELLENS, W
    MUSSGNUG, G
    SCHAFER, E
    HABETS, L
    PRAXIS UND KLINIK DER PNEUMOLOGIE, 1981, 35 : 902 - 904
  • [4] A MULTICENTER PHASE-II TRIAL OF CISPLATIN AND ORAL ETOPOSIDE (VP-16) IN INOPERABLE NON-SMALL-CELL LUNG-CANCER
    SPLINTER, T
    KOK, T
    KHO, S
    LAMERIS, H
    TENKATE, F
    DALESIO, O
    DOLMAN, B
    PALMEN, F
    BOUVY, J
    BURGHOUTS, J
    SIMONIS, F
    HARPER, P
    RANKIN, E
    VANREIJSWOUD, I
    VANHOOGENHUIJZE, J
    SEMINARS IN ONCOLOGY, 1986, 13 (03) : 97 - 103
  • [5] INITIAL THERAPY WITH CISPLATIN PLUS VP-16 IN SMALL-CELL LUNG-CANCER
    EINHORN, LH
    SEMINARS IN ONCOLOGY, 1986, 13 (03) : 5 - 9
  • [6] VP-16, IFOSFAMIDE AND CISPLATIN (VIP) FOR EXTENSIVE SMALL-CELL LUNG-CANCER
    EVANS, WK
    STEWART, DJ
    SHEPHERD, FA
    LOGAN, D
    GOSS, G
    MAROUN, JA
    WIERZBICKI, R
    WARNER, E
    LATREILLE, J
    DAHROUGE, S
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (03) : 299 - 303
  • [7] A RANDOMIZED STUDY COMPARING PLATINUM, DOXORUBICIN, AND VP-16 WITH PLATINUM, 4'-EPIDOXORUBICIN, AND VP-16 IN PATIENTS WITH NON-SMALL-CELL LUNG-CANCER
    ROSELL, R
    ABADESTEVE, A
    MORERA, J
    MONRAS, P
    MORENO, I
    RUIZ, J
    FERNANDEZ, C
    RIBASMUNDO, M
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1987, 10 (03): : 245 - 248
  • [8] TREATMENT OF ADVANCED NON-SMALL CELL LUNG-CANCER WITH INFUSIONAL VP-16 AND CISPLATINUM
    VALDIVIESO, M
    WOZNIAK, A
    BAKER, L
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 217 - 217
  • [9] VP-16 VS POLYCHEMOTHERAPY IN SMALL CELL LUNG-CANCER
    EAGAN, RT
    FRYTAK, S
    RUBIN, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR): : 243 - 243
  • [10] VP-16 AND CISPLATIN (P) AS FIRST LINE THERAPY FOR SMALL CELL LUNG-CANCER (SCLC)
    EVANS, WK
    DANG, P
    SHEPHERD, FA
    FELD, R
    OSOBA, D
    DEBOER, G
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1985, 8 (03): : A162 - A162
12345